Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Bruker, AB Sciex

Premium

Bruker this week introduced its Maxis II Q-TOF mass spec, which, the company said, is the new flagship in its TOF mass spec line.

The instrument offers 80,000 resolution at UPLC acquisition speeds as well as a high mass option for intact protein work such as biopharma characterization and electron transfer dissociation capability.


AB Sciex this week introduced its DiscoveryQuant 3.0 software for ADME work both in small molecule and biotherapeutic drug development.

According to the company the software expedites the method development process from existing database information, automates on-column optimization, analyzes and processes multiple samples at the same time, and is supported on all AB Sciex mass spec platforms.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.